Citation | Noronha, G; Barrett, K; Boccia, A; Brodhag, T; Cao, J; Chow, CP; Dneprovskaia, E; Doukas, J; Fine, R; Gong, X; Gritzen, C; Gu, H; Hanna, E; Hood, JD; Hu, S; Kang, X; Key, J; Klebansky, B; Kousba, A; Li, G; Lohse, D; Mak, CC; McPherson, A; Palanki, MS; Pathak, VP; Renick, J; Shi, F; Soll, R; Splittgerber, U; Stoughton, S; Tang, S; Yee, S; Zeng, B; Zhao, N; Zhu, H Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine--a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays. Bioorg Med Chem Lett17:602-8 (2007) [PubMed] Article |
---|
SMILES | Cc1cccc(C)c1-c1cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc2cc1C |(15.87,-35.45,;14.54,-36.22,;13.2,-35.45,;11.87,-36.22,;11.87,-37.77,;13.21,-38.53,;13.21,-40.07,;14.53,-37.76,;15.86,-38.53,;17.19,-37.76,;18.53,-38.52,;19.86,-37.74,;21.22,-38.51,;21.22,-40.07,;22.56,-40.83,;23.89,-40.06,;25.22,-40.83,;26.55,-40.06,;26.54,-38.52,;27.88,-37.74,;29.21,-38.51,;30.54,-37.73,;31.88,-38.5,;32.04,-40.02,;33.55,-40.34,;34.32,-39,;33.28,-37.86,;25.2,-37.75,;23.87,-38.53,;19.88,-40.85,;18.53,-40.08,;17.2,-40.85,;15.86,-40.08,;14.53,-40.84,)| |